IVF Research Today is a free monthly online journal that collates and summarizes the latest research about IVF, including details on in vitro fertilization, infertility, treatment, procedure, pregnancy, success rates.

Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Smeenk JM, Sweep FC, Zielhuis GA, Kremer JA, Thomas CM, Braat DD

Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. j.smeenk@obgyn.umcn.nl <j.smeenk@obgyn.umcn.nl>

Antimüllerian hormone (AMH) and other markers of ovarian reserve were assessed to determine their predictive value with respect to treatment outcome. In a multivariate regression analysis, AMH was found to be predictive of the number of oocytes and the number of embryos, but not of embryo quality or the chance of a pregnancy, after IVF/ICSI.

Published 1 January 2007 in Fertil Steril, 87(1): 223-6.
Full-text of this article is available online (may require subscription).

© 2004-2008 IVF Research Today. All Rights Reserved.